How to Quit Opioids: Withdrawal, Recovery, and What Actually Works

Opioid addiction kills more people in the United States each year than car accidents. It's not because the people who develop it lack willpower or character. It's because opioids create the most powerful physical dependence of any class of drugs — one that overrides the brain's decision-making systems in ways that aren't addressable through resolve alone.

If you're trying to quit opioids — or helping someone who is — this guide explains what's actually happening in the brain, what recovery looks like, and what the evidence says actually works.

What Opioids Do to the Brain

Opioids — whether heroin, fentanyl, oxycodone, hydrocodone, or morphine — bind to mu-opioid receptors throughout the brain and body. These receptors naturally respond to the brain's own endorphins, regulating pain, mood, and reward. When opioids bind to them, they produce a flood of dopamine in the reward circuit — a signal far more powerful than anything the brain produces naturally.

With repeated use, the brain adapts in two critical ways. First, it reduces its own endorphin production, creating a deficit that makes normal life feel grey and flat without opioids. Second, it downregulates opioid receptors, creating tolerance — the need for more of the drug to achieve the same effect. The person using opioids eventually isn't getting high; they're using to feel normal.

This is why the phrase "just stop" misunderstands the problem. The brain's reward and pain systems have been structurally reorganised around the drug. Recovery is a process of restructuring them back — and that takes time.

The Opioid Withdrawal Timeline

Withdrawal timing depends on the half-life of the specific opioid. Short-acting opioids (heroin, oxycodone, hydrocodone) produce earlier, more intense withdrawal. Longer-acting opioids (methadone, buprenorphine) produce slower, more extended withdrawal.

Short-acting opioids (heroin, oxycodone)

• Hours 6–12: Anxiety, restlessness, drug craving, yawning, runny nose
• Hours 12–36: Peak symptoms — muscle aches, sweating, chills, nausea, vomiting, diarrhoea, insomnia, severe restlessness (the characteristic "restless legs" of opiate withdrawal), goosebumps
• Days 3–5: Symptoms begin to subside. Physical acute withdrawal is largely complete by day 5–7 for most short-acting opioids

Post-Acute Withdrawal Syndrome (PAWS)

After acute withdrawal ends, many people enter a prolonged period of psychological and neurological symptoms that can last months: depression, anxiety, sleep disturbance, difficulty experiencing pleasure (anhedonia), irritability, and intense cravings triggered by people, places, and emotions associated with use. This is PAWS — and it's the period when most relapses occur. Understanding PAWS is critical because it explains why people who successfully detox still relapse weeks or months later. The brain is still healing.

What Actually Works: The Evidence

Medication-Assisted Treatment (MAT)

MAT — using medications like buprenorphine (Suboxone), methadone, or naltrexone (Vivitrol) as part of a recovery plan — is the most evidence-backed approach to opioid use disorder. It consistently outperforms abstinence-only approaches in every outcome that matters: retention in treatment, overdose death, illicit drug use, and HIV transmission.

Buprenorphine (Suboxone) is a partial opioid agonist — it activates opioid receptors partially, preventing withdrawal without producing a significant high. It dramatically reduces cravings and is prescribed by certified physicians. It can be taken at home, which is a major practical advantage.

Methadone is a full opioid agonist used at a controlled dose to eliminate withdrawal. It has the longest track record of any opioid treatment and is highly effective, though it requires daily clinic attendance in most countries.

Naltrexone (Vivitrol) works differently — it blocks opioid receptors entirely, so opioids produce no effect. It's particularly useful for people who have successfully detoxed and want pharmacological support for staying clean. The injectable monthly form (Vivitrol) improves adherence significantly over the daily pill.

The false idea that MAT is "just trading one drug for another" is contradicted by decades of evidence. People on MAT hold jobs, maintain relationships, and rebuild lives. That's the goal of recovery — not simply the absence of a specific molecule.

Behavioural Treatment

MAT works best alongside behavioural intervention. Contingency management — a treatment approach that provides real incentives for clean urine samples — has among the strongest evidence of any psychosocial intervention for opioid use disorder. CBT helps people identify and change the thought patterns and environmental triggers that drive use. Both are additive to medication, not alternatives to it.

Peer Support

Having ongoing connection with people who understand addiction from the inside — SMART Recovery, Narcotics Anonymous, online sober communities — reduces relapse risk significantly. Isolation is one of the most powerful predictors of relapse. Recovery from opioids is not a solo project.

The Overdose Risk After Detox

This point deserves its own section because it saves lives: tolerance drops within days of stopping opioid use. A dose that was tolerated before detox can be lethal afterward. The majority of opioid overdose deaths occur in people who have recently been abstinent — after leaving prison, after completing a detox programme, after a hospitalisation. If you or someone you know has recently detoxed, this is the highest-risk window, and it's why having naloxone (Narcan) available is not optional — it's essential.

If you're in recovery and you're considering using "just once," know that your body no longer has the tolerance it had. Plan accordingly.

What Long-Term Recovery Looks Like

Opioid use disorder is increasingly understood as a chronic condition — like diabetes or hypertension — that requires ongoing management rather than a one-time cure. Most people who achieve lasting recovery do not do so after a single treatment episode. They do so after multiple attempts, accumulating longer and longer periods of stability.

Across those attempts, a few things consistently predict better outcomes: stable housing, employment or structured activity, social support, ongoing treatment engagement (whether medication or counselling), and meaningful connection to something beyond the addiction. The research is consistent: recovery is not an event. It's a process that builds over years.

Tracking daily progress, building accountability, and maintaining structure during the PAWS window — when motivation is low and the brain is still recalibrating — is where the daily work happens. That work looks unglamorous from the outside. But it's what compounds into years of stability.